Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.09
-1.82 (-6.30%)
At close: Dec 5, 2025, 4:00 PM EST
27.18
+0.09 (0.33%)
After-hours: Dec 5, 2025, 7:58 PM EST
Beam Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,674 | 1,974 | 2,159 | 2,692 | 5,327 | 4,611 | |
| Market Cap Growth | 32.82% | -8.58% | -19.78% | -49.47% | 15.54% | - | |
| Enterprise Value | 1,750 | 1,210 | 1,318 | 1,776 | 4,539 | 4,443 | |
| Last Close Price | 27.09 | 24.80 | 27.22 | 39.11 | 79.69 | 81.64 | |
| PS Ratio | 45.66 | 31.08 | 5.72 | 44.18 | 102.75 | 192105.00 | |
| PB Ratio | 2.76 | 2.69 | 2.20 | 3.67 | 6.44 | 18.77 | |
| P/TBV Ratio | 2.77 | 2.69 | 2.20 | 3.67 | 6.44 | 18.77 | |
| P/OCF Ratio | - | - | - | 119.48 | - | - | |
| EV/Sales Ratio | 31.42 | 19.05 | 3.49 | 29.15 | 87.56 | 185109.63 | |
| Debt / Equity Ratio | 0.16 | 0.22 | 0.18 | 0.25 | 0.18 | 0.44 | |
| Asset Turnover | 0.05 | 0.05 | 0.27 | 0.04 | 0.05 | 0 | |
| Quick Ratio | 5.89 | 4.67 | 5.79 | 4.82 | 5.93 | 2.93 | |
| Current Ratio | 6.02 | 4.82 | 5.89 | 4.89 | 5.96 | 3.01 | |
| Return on Equity (ROE) | -47.19% | -43.94% | -15.46% | -37.06% | -69.13% | -112.32% | |
| Return on Assets (ROA) | -23.48% | -20.26% | -7.88% | -15.02% | -15.41% | -27.30% | |
| Return on Capital (ROIC) | -28.15% | -25.35% | -10.67% | -22.40% | -22.36% | -34.19% | |
| Return on Capital Employed (ROCE) | -41.30% | -45.10% | -14.10% | -30.30% | -18.80% | -38.00% | |
| Earnings Yield | -15.51% | -19.09% | -6.14% | -10.74% | -6.96% | -4.22% | |
| FCF Yield | -13.18% | -18.05% | -8.47% | -0.98% | -2.12% | -2.43% | |
| Buyback Yield / Dilution | -14.73% | -6.69% | -10.19% | -9.01% | -37.44% | -621.24% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.